当前位置： SCI文献检索 > PEDIATRIC BLOOD & CANCER期刊下所有文献 > Clinical management of pediatric aggressive fibromatosis involving the mandible.

Clinical management of pediatric aggressive fibromatosis involving the mandible.

Abstract：

BACKGROUND:Pediatric aggressive fibromatosis (AF) is a rare, benign tumor with locally infiltrative growth. Therefore, how to prevent reoccurrence while maintaining the mandible contour and continuity as much as possible is very important when the mandible is involved. PROCEDURE:We selected 10 pediatric patients with AF involving the mandible in our department between January 2001 and December 2011. Patient clinical data, including patient characteristics, symptoms at presentation, management, and treatment outcome, were reviewed. RESULTS:Patients' ages ranged from 3 to 16 years with six males and four females. According to imaging, there were three cases where the tumor adhered to the mandible; the periosteum was resected with the tumor, followed by cryotherapy or cauterization. Another five cases involved the destruction of the periosteum and the cortical plate. Resection of the involved mandible with the tumor was performed, and the margin was trimmed. In the last two cases, the tumor had invaded the whole ramus, and the immediate iliac graft was operated on after resecting the lesions. Neither radiotherapy (RT) nor chemotherapy was used. There was no recurrence or contour defect of the face. The function of the mandible was not affected, and only one case showed a slight limitation when opening the mouth. CONCLUSIONS:For the treatment of pediatric AF, we recommend complete tumor resection. As for the involved mandible, preserving the mandible contour and continuity as much as possible and providing adjunctive therapy, such as cryotherapy or cauterization, are vital. RT is not recommended.

journal_name

Pediatr Blood Cancer

journal_title

Pediatric blood & cancer

authors

Zhou Y,Zhang Z,Fu H,Qiu W,Wang L,He Y

doi

10.1002/pbc.24145

subject

Has Abstract

pub_date

2012-10-01 00:00:00

pages

648-51

issue

4

eissn

1545-5009

issn

1545-5017

journal_volume

59

pub_type

杂志文章

相关文献

PEDIATRIC BLOOD & CANCER文献大全
  • The role of myeloablative chemotherapy with autologous hematopoietic cell rescue in central nervous system germ cell tumors.

    abstract：:This review of the experience of high dose chemotherapy in patients with recurrent or refractory intracranial germ cell tumor confirms that sustained tumor control can be achieved with this modality both in germinoma and non-germinomatous germ cell tumors. Data from cooperative groups in Europe and North America sugge...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.22376

    authors： Bouffet E

    更新日期：2010-04-01 00:00:00

  • Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation.

    abstract：:Pneumocystis jiroveci pneumonia (PCP) is a serious complication in patients receiving chemotherapy or hematopoietic stem cell transplantation. Current recommendations for trimethoprim-sulfamethoxazole (TMP-SMZ) dosing as PCP prophylaxis in immunocompromised patients are based on either daily dosing or dosing three con...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21774

    authors： Ohata Y,Ohta H,Hashii Y,Tokimasa S,Ozono K,Hara J

    更新日期：2009-01-01 00:00:00

  • Protein biomarkers for incident deep venous thrombosis in critically ill adolescents: An exploratory study.

    abstract：BACKGROUND:There are no tests to identify critically ill children at high risk of deep venous thrombosis (DVT). In this exploratory study, we aimed to identify proteins that are associated with incident DVT in critically ill adolescents. PROCEDURE:Plasma samples were obtained from critically ill adolescents within 24 ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.28159

    authors： Tala JA,Polikoff LA,Pinto MG,Li S,Trakas E,Miksa M,Gertz S,Faustino EVS,THEIA Study Investigators.

    更新日期：2020-04-01 00:00:00

  • The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL).

    abstract：:Hyperglycemia during induction chemotherapy for childhood acute lymphoblastic leukemia (ALL) has been inconsistently associated with risk of infection. We investigated the incidence of hyperglycemia during induction for childhood ALL in a retrospective cohort study of 144 patients treated on a single national protocol...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24689

    authors： Dare JM,Moppett JP,Shield JP,Hunt LP,Stevens MC

    更新日期：2013-12-01 00:00:00

  • Extremely high birth prevalence of sickle cell disease in rural Tanzania.

    abstract：BACKGROUND/OBJECTIVES:Sickle cell disease (SCD) is an important, hidden cause of childhood mortality worldwide. It is most prevalent in sub-Saharan Africa where national newborn screening programs remain unavailable and most children in rural areas are never diagnosed. We conducted a study at a rural district hospital ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28620

    authors： Eastburg L,Peckham A,Kawira E,Chirangi B,Adler D,Akungo BD,Smart LR,Ambrose EE

    更新日期：2020-11-01 00:00:00

  • HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

    abstract：:In HLH-94, the first prospective international treatment study for hemophagocytic lymphohistiocytosis (HLH), diagnosis was based on five criteria (fever, splenomegaly, bicytopenia, hypertriglyceridemia and/or hypofibrinogenemia, and hemophagocytosis). In HLH-2004 three additional criteria are introduced; low/absent NK...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21039

    authors： Henter JI,Horne A,Aricó M,Egeler RM,Filipovich AH,Imashuku S,Ladisch S,McClain K,Webb D,Winiarski J,Janka G

    更新日期：2007-02-01 00:00:00

  • Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia.

    abstract：BACKGROUND:A total of 201 pediatric cases of acute lymphoblastic leukemia were treated with the ALL-96 protocol by the Kyushu-Yamaguchi Children's Cancer Study Group. PROCEDURE:Risk stratification was based on white cell counts, immunophenotype, the presence of central nervous system disease at diagnosis, organomegaly...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1002/pbc.22528

    authors： Nagatoshi Y,Matsuzaki A,Suminoe A,Inada H,Ueda K,Kawakami K,Yanai F,Nakayama H,Moritake H,Itonaga N,Hotta N,Fujita K,Hidaka Y,Yamanaka T,Kawano Y,Okamura J

    更新日期：2010-08-01 00:00:00

  • Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.

    abstract：:Steroid-induced neuropsychological side effects impact quality of life in children with acute lymphoblastic leukemia. Dexamethasone induces more metabolic side effects than prednisone. To evaluate whether dexamethasone also leads to more neuropsychological side effects, we reviewed all available literature. Randomized...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.24988

    authors： Warris LT,van den Heuvel-Eibrink MM,den Hoed MA,Aarsen FK,Pieters R,van den Akker EL

    更新日期：2014-07-01 00:00:00

  • Oral health and dental anomalies in patients treated for leukemia in childhood and adolescence.

    abstract：BACKGROUND:This study was conducted to evaluate oral health and dental anomalies in children treated for acute lymphoblastic leukemia (ALL) and to compare results with those of a group of healthy children matched for sex and age. PROCEDURE:Fifty-six children treated for ALL and 56 healthy controls were examined for de...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22108

    authors： Maciel JC,de Castro CG Jr,Brunetto AL,Di Leone LP,da Silveira HE

    更新日期：2009-09-01 00:00:00

  • Psychological distress in long-term survivors of solid tumors diagnosed in childhood: a report from the childhood cancer survivor study.

    abstract：PURPOSE:To evaluate and compare psychological distress in long-term survivors of solid tumors diagnosed in childhood and their siblings, and to identify significant correlates of psychological distress. PROCEDURE:Adult survivors (2,778) of solid tumors diagnosed in childhood and 2,925 siblings completed a long-term fo...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.20914

    authors： Zebrack BJ,Zevon MA,Turk N,Nagarajan R,Whitton J,Robison LL,Zeltzer LK

    更新日期：2007-07-01 00:00:00

  • Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT).

    abstract：BACKGROUND:Low expression of HLA class II antigens has been associated with more aggressive disease in several human malignancies including adult adrenocortical tumors (ACT), but their clinical relevance in pediatric ACT needs to be investigated. PROCEDURE:This study analyzed the expression profile of three class II h...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25118

    authors： Leite FA,Lira RC,Fedatto PF,Antonini SR,Martinelli CE Jr,de Castro M,Neder L,Ramalho LN,Tucci S Jr,Mastelaro MJ,Seidinger AL,Cardinalli IA,Yunes JA,Brandalise SR,Tone LG,Scrideli CA

    更新日期：2014-11-01 00:00:00

  • Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment.

    abstract：INTRODUCTION:Our objectives were to design and validate methods to identify relapse and hematopoietic stem cell transplantation (HSCT) in children with acute lymphoblastic leukemia (ALL) using administrative data representing hospitalizations at US pediatric institutions. METHODS:We developed daily billing and ICD-9 c...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28315

    authors： Cahen VC,Li Y,Getz KD,Elgarten CW,DiNofia AM,Wilkes JJ,Winestone LE,Huang YV,Miller TP,Gramatges MM,Rabin KR,Fisher BT,Aplenc R,Seif AE

    更新日期：2020-05-11 00:00:00

  • Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.

    abstract：BACKGROUND:Osteopenia has been reported in children surviving acute lymphoblastic leukemia and brain tumors, apparently as a consequence of therapy. It has been suggested that cranial irradiation may play a role in the development of this complication. In order to explore that possibility, we examined survivors of brai...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.20512

    authors： Odame I,Duckworth J,Talsma D,Beaumont L,Furlong W,Webber C,Barr R

    更新日期：2006-03-01 00:00:00

  • Variation in hospital admission from the emergency department for children with cancer: A Pediatric Health Information System study.

    abstract：BACKGROUND:Children with cancer experience a wide range of conditions that require urgent evaluation in the emergency department (ED), yet variation in admission rates is poorly documented. PROCEDURE:We performed a retrospective cohort study using the Pediatric Health Information System of ED encounters by children wi...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28140

    authors： Mueller EL,Jacob SA,Cochrane AR,Carroll AE,Bennett WE Jr

    更新日期：2020-06-01 00:00:00

  • Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors.

    abstract：BACKGROUND:To determine the maximum-tolerated duration and dose-limiting toxicity of a daily schedule of orally administered cyclophosphamide and topotecan in pediatric patients with recurrent or refractory malignant solid tumors. METHODS:Patients received oral cyclophosphamide (50 mg/m2/dose) in the morning followed ...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.10456

    authors： Bowers DC,Aquino VM,Leavey PJ,Bash RO,Journeycake JM,Tomlinson G,Mulne AF,Haynes HJ,Winick NJ

    更新日期：2004-01-01 00:00:00

  • Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.

    abstract：BACKGROUND:We investigated the spectrum, frequency, and risk factors for renal, gastrointestinal, and hepatic late adverse effects in survivors of childhood acute myeloid leukemia (AML) without relapse treated with chemotherapy alone according to three consecutive AML trials by the Nordic Society of Pediatric Hematolog...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25069

    authors： Skou AS,Glosli H,Jahnukainen K,Jarfelt M,Jónmundsson GK,Malmros-Svennilson J,Nysom K,Hasle H,Nordic Society of Pediatric Hematology and Oncology.

    更新日期：2014-09-01 00:00:00

  • One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.

    abstract：BACKGROUND:Iron overload is well documented in patients with β-thalassemia major, and patients who have undergone hematopoietic stem cell transplantation (HSCT) remain at risk as a result of pre- and immediate post-HSCT transfusions. PROCEDURE:This is a prospective, randomized, 1-year clinical trial that compares the ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,随机对照试验

    doi：10.1002/pbc.26213

    authors： Inati A,Kahale M,Sbeiti N,Cappellini MD,Taher AT,Koussa S,Nasr TA,Musallam KM,Abbas HA,Porter JB

    更新日期：2017-01-01 00:00:00

  • Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.

    abstract：PURPOSE:NWTS-5 was a multi-institutional clinical trial for patients less than 16 years of age at diagnosis with specific renal neoplasms who were diagnosed between August 1, 1995 and May 31, 2002. A uniform approach to the treatment of patients with relapse was employed. PATIENTS AND METHODS:Seventy-two patients who ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.20822

    authors： Green DM,Cotton CA,Malogolowkin M,Breslow NE,Perlman E,Miser J,Ritchey ML,Thomas PR,Grundy PE,D'Angio GJ,Beckwith JB,Shamberger RC,Haase GM,Donaldson M,Weetman R,Coppes MJ,Shearer P,Coccia P,Kletzel M,Macklis R,To

    更新日期：2007-05-01 00:00:00

  • Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies.

    abstract：:Essential thrombocythemia is a rare myleoproliferative disorder in pediatrics. This myleoproliferative disorder is characterized by excessive proliferation of megakaryocytes and sustained elevation of platelet count. Reactive thrombocytosis is a more common cause of elevated platelet counts among children. We describe...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21218

    authors： Robins EB,Niazi M

    更新日期：2008-04-01 00:00:00

  • Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting.

    abstract：:Treatment recommendations for endemic Burkitt lymphoma (BL) in settings with only minimum requirements for curative treatment (PODC setting 1) are described. The reported cure rate for endemic BL is usually <50%. Facilities within setting 1 differ. Three treatment schedules are proposed based on: (1) when accurate sta...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,实务指引

    doi：10.1002/pbc.24407

    authors： Hesseling P,Israels T,Harif M,Chantada G,Molyneux E,Pediatric Oncology in Developing Countries.

    更新日期：2013-03-01 00:00:00

  • A proposal for an international retinoblastoma staging system.

    abstract：BACKGROUND:Although intra-retinal tumor has long been staged presurgically according to the Reese-Ellsworth (R-E) system, retinoblastoma differs from other pediatric neoplasms in never having had a widely accepted classification system that encompasses the entire spectrum of the disease. Comparisons among studies that ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.20606

    authors： Chantada G,Doz F,Antoneli CB,Grundy R,Clare Stannard FF,Dunkel IJ,Grabowski E,Leal-Leal C,Rodríguez-Galindo C,Schvartzman E,Popovic MB,Kremens B,Meadows AT,Zucker JM

    更新日期：2006-11-01 00:00:00

  • Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.

    abstract：BACKGROUND:Children and adolescents with Non-Hodgkin lymphoma (NHL) and mature B-cell leukemia (B-ALL) have an excellent prognosis with contemporary chemotherapy stratified according to the histologic subtype and clinical stage of disease. However, a small subset of patients does not respond to front-line therapy or su...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.20121

    authors： Attarbaschi A,Dworzak M,Steiner M,Urban C,Fink FM,Reiter A,Gadner H,Mann G

    更新日期：2005-01-01 00:00:00

  • Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer.

    abstract：:Increasingly young people survive cancer in childhood and as a result complications of its treatment are becoming more common and important. Premature ovarian failure is recognized as a complication of radiotherapy to a field that includes the pelvis and alkylating-agent-based chemotherapy. Young pre-pubertal girls ar...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.22012

    authors： Johnston RJ,Wallace WH

    更新日期：2009-08-01 00:00:00

  • Monosomy 7/del (7q) in inherited bone marrow failure syndromes: A systematic review.

    abstract：:Inherited bone marrow failure syndromes (IBMFS) are rare cancer predisposition syndromes with an especially high risk of transformation to myelodysplastic syndrome (MDS) and/or acute myeloid leukemia (AML). We performed a retrospective systematic review of reported MDS/AML arising in the eight most common IBMFS to det...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.26714

    authors： Pezeshki A,Podder S,Kamel R,Corey SJ

    更新日期：2017-12-01 00:00:00

  • Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.

    abstract：BACKGROUND:In malaria-endemic countries in West Africa, sickle cell disease (SCD) contributes to childhood mortality. Historically, Liberia had regions wherein hemoglobin S and beta-thalassemia trait were mutually exclusive. Data on hemoglobinopathies in the Monrovia, the capital, are outdated and do not reflect urban ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25875

    authors： Tubman VN,Marshall R,Jallah W,Guo D,Ma C,Ohene-Frempong K,London WB,Heeney MM

    更新日期：2016-04-01 00:00:00

  • Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.

    abstract：BACKGROUND:Bleomycin is associated with pulmonary toxic side effects including pneumonitis and pulmonary fibrosis. We evaluated the prevalence of long-term pulmonary function abnormalities in children receiving bleomycin therapy in the context of current chemotherapeutic regimens. METHODS:A retrospective review of pat...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25098

    authors： De A,Guryev I,LaRiviere A,Kato R,Wee CP,Mascarenhas L,Keens TG,Venkatramani R

    更新日期：2014-09-01 00:00:00

  • Clinical advances in hemophilia management.

    abstract：:Hemophilia is an excellent example in medicine where clinical translation of basic science discoveries has transformed the gloomy outlook of the disease. This review provides an overview of clinical advances in hemophilia management with a specific focus on the molecular heterogeneity of the disease and progress in ma...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.23193

    authors： Sharathkumar AA,Carcao M

    更新日期：2011-12-01 00:00:00

  • Esophagitis associated with multimodality management of pediatric Ewing sarcoma of thorax.

    abstract：BACKGROUND:Ewing sarcoma of the thoracic spine and chest wall is frequently treated with concurrent chemotherapy and radiation therapy (RT). Treatment-related acute esophagitis can lead to hospitalization and treatment delays. The aim of this study was to analyze the incidence, risk factors, and management of esophagit...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.27006

    authors： Agarwal V,Logie N,Morris CG,Bradley JA,Rotondo RL,Bradfield SM,Indelicato DJ

    更新日期：2018-06-01 00:00:00

  • Clinical phenotype and genetic analysis of RPS19, RPL5, and RPL11 genes in Greek patients with Diamond Blackfan Anemia.

    abstract：BACKGROUND:Diamond Blackfan Anemia (DBA) is a rare congenital, bone marrow failure syndrome characterized by normochromic macrocytic anemia, reticulocytopenia and absence or insufficiency of erythroid precursors in normocellular bone marrow, frequently associated with somatic malformations. Here, we present our finding...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25183

    authors： Delaporta P,Sofocleous C,Stiakaki E,Polychronopoulou S,Economou M,Kossiva L,Kostaridou S,Kattamis A

    更新日期：2014-12-01 00:00:00

  • Hyperbaric oxygen should not be used in the management of hemorrhagic cystitis in patients with Fanconi anemia.

    abstract：:Hemorrhagic cystitis (HC) is a common complication after stem cell transplantation (SCT) that occurs more frequently in patients with Fanconi anemia (FA) because of hypersensitivity of their cells to the agents used in the preparation for SCT (chemo and radiation). Many HC cases respond to therapy with hyperhydration ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.20692

    authors： Al-Seraihi A,Ayas M

    更新日期：2007-11-01 00:00:00